Aclaris Therapeutics, Inc. — SCHEDULE 13G Filings
5 SCHEDULE 13G filings on record
This page lists all SCHEDULE 13G filings submitted to the SEC by Aclaris Therapeutics, Inc. (ACRS), sorted by most recent first. Each row links to the full filing on EdgarLookup. Aclaris Therapeutics, Inc. has filed 5 SCHEDULE 13G documents with the SEC since 2012. To view all SEC filings by Aclaris Therapeutics, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
10-Q/A
144
3
4
4/A
424B3
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
D/A
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
POS AM
PRE 14A
S-1
S-1/A
S-3
S-3ASR
S-3MEF
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G | — | 0001172661-26-001355 | Mar 17, 2026 | — |
| SCHEDULE 13G | — | 0000932471-25-000787 | Jul 29, 2025 | — |
| SCHEDULE 13G | — | 0002052113-25-002984 | Jul 17, 2025 | — |
| SCHEDULE 13G | — | 0001104659-25-044500 | May 5, 2025 | — |
| SCHEDULE 13G | — | 0000902664-25-000858 | Feb 12, 2025 | — |